招银证券：给予爱康医疗(01789.HK)“增持”评级 目标价11.44港元 当前独家
【资料图】
招银证券2月17日发布公告。Maintain BUY. We believe the VBP would drive AK Medical’s solid growth and the long term share gains. We expect its revenue growth at a CAGR of 29.6% from 2023E to 2025E and raise our TP from HK$9.20 to HK$11.44 based on a 9-year DCF model (WACC: 9.54%, terminal growth rate: 3.0%).
X 关闭
Copyright 2015-2022 华东服务网 版权所有京ICP备2022016840号-41
邮箱：2 913 236 @qq.com